Foley Hoag represented GreenLight., while Latham & Watkins represented Environmental Impact Acquisition Corp. in the transaction. GreenLight Biosciences, Inc., a biotechnology company dedicated to making ribonucleic acid...
Environmental Impact’s Business Combination with GreenLight Biosciences
Pear Therapeutics’ $20M Series D Extension
Foley Hoag LLP advised Pear Therapeutics, Inc. on the deal. Pear Therapeutics, Inc., a pioneer of prescription digital therapeutics (PDTs), announced the extension of its Series D...